Treatment with tocilizumab leads to the disappearance of olecranon rheumatoid nodules

Int J Dermatol. 2012 Feb;51(2):197-8. doi: 10.1111/j.1365-4632.2011.04966.x. Epub 2011 Sep 14.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Female
  • Humans
  • Olecranon Process
  • Rheumatoid Nodule / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab